Pure Global
NCT04332263

Neuromuscular Electrical Stimulation in ICU Patients

Development and Application of a Portable Electrical Stimulator With Biofeedback to Increase Mobility and Improve the Neuromuscular Function of Critical Adult Patients in Intensive Care Units
Federal University of Rio Grande do Sul·ClinicalTrials.gov·otherEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intensive Care Unit Acquired Weakness
Drug/Device/Intervention
Neuromuscular Electrical Stimulation - NMES
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Federal University of Rio Grande do Sul
Location
Porto Alegre, Brazil
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2022
End date
Dec 20, 2024
Enrollment
56 participants
Primary outcome

Total ICU time,Mechanical ventilation time,Weaning time,Change in knee extensor evoked force,Knee extensor maximal voluntary isometric contraction,Knee extensor muscle quality: Real-time ultrasound 9 MHz frequency,Rectus femoris cross-sectional area,Knee extensors muscle thickness

Summary

The aim of the present study is to evaluate the effects of neuromuscular electrical
 stimulation (NMES) combined with conventional physiotherapy (Experimental Group), compared to
 conventional physiotherapy only (Control Group) in critically ill Intensive Care Unit (ICU)
 patients, by means of a randomized controlled clinical trial. The investigators expect that
 the NMES program will be able to reduce muscle structure and function losses compared to
 control group, and will improve muscle quality faster, will reduce the ventilation time and
 the total time spent at the ICU, as well as improve functionality of these patients. In
 addition, the researchers expect to understand which mechanisms determine such adaptations in
 the musculoskeletal system of these patients.

ICD-10 classifications
Acute respiratory failureAcute renal failure with medullary necrosisAcute renal failureAcute renal failure, unspecifiedOther acute renal failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04332263
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04332263 through Pure Global AI's free database. This phase not specified trial is sponsored by Federal University of Rio Grande do Sul and is currently Enrolling by invitation. The study focuses on Intensive Care Unit Acquired Weakness. Target enrollment is 56 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.